Outcome of treatment for distal bile duct cancer.

Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol (2009) 2.17

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer (2009) 1.54

Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg (2005) 1.37

E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer (2011) 1.34

Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg (2007) 1.29

2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford) (2013) 0.99

Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg (2007) 0.96

Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. Ann Surg (1999) 0.96

Carcinoma of the middle bile duct: is bile duct segmental resection appropriate? World J Gastroenterol (2009) 0.92

Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol (2011) 0.92

Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today (2014) 0.89

Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) (2008) 0.88

Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg (2007) 0.87

Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma. HPB (Oxford) (2011) 0.86

Impact of reconstruction methods on outcome of pancreatoduodenectomy in pancreatic cancer patients. World J Surg (2005) 0.85

Prognostic factors in patients with middle and distal bile duct cancers. World J Gastroenterol (2014) 0.83

Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. HPB (Oxford) (2008) 0.83

Cholangiocarcinoma: a 7-year experience at a single center in Greece. World J Gastroenterol (2008) 0.79

Prognostic factors following surgical resection of distal bile duct cancer. J Korean Surg Soc (2013) 0.78

Hepatic metastasis from bile duct cancer of the ampulla is effectively controlled by multidisciplinary treatment including S-1, gemcitabine and bevacizumab: A case report. Oncol Lett (2010) 0.75

Pancreaticoduodenectomy for secondary periampullary cancer following extrahepatic bile duct cancer resection. Ann Surg Treat Res (2014) 0.75

Biological effects of RNAi targeted inhibiting Tiam1 gene expression on cholangiocarcinoma cells. Int J Clin Exp Pathol (2015) 0.75

Comparison of preoperative evaluation of malignant low-level biliary obstruction using plain magnetic resonance and coronal liver acquisition with volume acceleration technique alone and in combination. Eur J Med Res (2015) 0.75

Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. Mod Pathol (2016) 0.75

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24

Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA (1995) 11.90

Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05

A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry (1996) 7.80

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04

Is duodenitis a dyspeptic myth? Lancet (1977) 6.17

Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg (2001) 5.94

Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90

Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40

Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88

Differences in the use of psychiatric outpatient services between the United States and Ontario. N Engl J Med (1997) 4.78

Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry (1999) 4.57

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51

An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26

SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18

Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A (2007) 4.16

Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry (2001) 4.07

Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96

A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg (1978) 3.91

Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 3.85

Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery (1986) 3.22

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. J Clin Oncol (2007) 3.07

Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06

Adequacy and duration of antidepressant treatment in primary care. Med Care (1992) 3.04

Segment-oriented hepatic resection in the management of malignant neoplasms of the liver. J Am Coll Surg (1998) 3.04

Prospective study of colorectal cancer in the west of Scotland: 10-year follow-up. Br J Surg (1990) 3.01

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98

Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97

Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91

The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90

Management of the Mirizzi syndrome and the surgical implications of cholecystcholedochal fistula. Br J Surg (1990) 2.89

Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87

Rethinking practitioner roles in chronic illness: the specialist, primary care physician, and the practice nurse. Gen Hosp Psychiatry (2001) 2.82

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg (1998) 2.81

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80

Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial. Br J Surg (1984) 2.78

The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77

Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol (1993) 2.71

Giant hemangiomas of the liver. Ann Surg (1970) 2.70

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol (2009) 2.69

Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65

Orthotopic and heterotopic liver homografts in man. Ann Surg (1970) 2.63

Soft tissue sarcomas. Curr Probl Surg (1996) 2.62

Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60

Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer (1989) 2.57

The enigma of desmoid tumors. Ann Surg (1999) 2.57

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg (2001) 2.57

Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg (1999) 2.57

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol (2008) 2.52

Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol (2000) 2.48

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47

Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg (2000) 2.43

Regional resection of cancer of the pancreas: a new surgical approach. Surgery (1973) 2.43

A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol (1976) 2.42

Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39

Epidemiology of cancer of the pancreas. J Natl Cancer Inst (1973) 2.37

Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg (1975) 2.31

Recent advances in the management of cholangiocarcinomas. Semin Liver Dis (1994) 2.30

Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg (1974) 2.30

Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol (1999) 2.30

The Drosophila RAD21 cohesin persists at the centromere region in mitosis. Curr Biol (2000) 2.29

Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet (1984) 2.28

Malignant schwannoma. A clinicopathologic study. Cancer (1973) 2.26

DNA methylation predicts survival and response to therapy in patients with myelodysplastic syndromes. J Clin Oncol (2009) 2.23

Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res (2009) 2.21

Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis Colon Rectum (1988) 2.20

One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry (1996) 2.18

Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17

Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry (1990) 2.13

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol (2008) 2.12

Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol (1997) 2.10

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09

Cannulation of papilla of vater via fiber-duodenoscope. Assessment of retrograde cholangiopancreatography in 60 patients. Lancet (1972) 2.09

Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg (1993) 2.07

Percutaneous transhepatic drainage in obstructive jaundice: advantages and problems. Br J Surg (1982) 2.07

Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06

Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg (1984) 2.06

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06

Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05

Somatization: a spectrum of severity. Am J Psychiatry (1991) 2.03

Regional pancreatectomy for cancer of the pancreas, ampulla, and other related sites. Tumor staging and results. Ann Surg (1984) 2.03

Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03

One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg (1994) 2.03